Finding ways of curbing government expenditure on the PBS while maintaining social equity and access to 'essential' medicines is at the centre of ongoing public debate. This paper outlines future developments that will extend the current model to include health outcomes. Adding health outcomes represents a path-breaking advancement in modelling the PBS and will advance...

In recent years outlays on the Pharmaceutical Benefits Scheme have increased rapidly, prompting both attempts by government to reduce growth in outlays and renewed interest in the characteristics of the beneficiaries of the Scheme. This paper, using a microsimulation model of the PBS, analyses the distributional impact of Commonwealth Government outlays on the PBS, by...

This study examines the socioeconomic status of NSW hospital patients in 1999-2000 and projects likely hospital costs to 2009-10. It draws upon unique patient based datasets from NSW public and private hospitals that include hospital admissions, as well as the associated treatment costs in each of the four years to 1999-2000.

In this paper presented to the Health Outcomes 2003 Conference, the authors examine whether the average cost of treating patients changes in line with variations in their socioeconomic status. Given concerns about ever increasing government health spending and the distributional impact of such spending, this paper aims to improve our understanding of health inequalities in...

This paper describes the structure of the Cost Benefit Model of Diabetes Prevention and Care and lists the data sources used and assumptions embedded in the model. Agnes Walker, Stephen Colagiuri and Michele McLennan validate the model through checks of model outputs against data published by other organisations. They also discuss the sensitivity of model...